ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1127

Extracellular Macrophage Migration Inhibitory Factor Is Essential for Hypoxia-Induced Angiogenesis in a Hypoxia Inducible Factor Independent Manner

Mathias Mursell1,2, Martin Hahne1,2,3, Peggy Kunath1,2, Cindy Strehl1,2, Paula Hoff1,2, Frank Buttgereit2 and Timo Gaber1,2, 1German Rheumatism Research Center (DRFZ), Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 3Miltenyi Biotec GmbH, Bergisch Gladbach, Germany

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Angiogenesis, endothelial cells, macrophage migration inhibitory factor (MIF) and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis - Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Angiogenesis is a hallmark of the pathogenesis of rheumatoid arthritis (RA) but also of other inflammatory processes, tissue regeneration and progressing tumors. In RA, the neovascular network is dysfunctional and fails to restore tissue oxygen homeostasis, so that the inflamed joint remains markedly hypoxic. The hypoxia-induced multifunctional and pro-inflammatory protein macrophage migration inhibitory factor (MIF) participates in the regulation of hypoxia-induced angiogenesis. At cellular level, hypoxia is detected by a mechanism that regulates the amount of the oxygen-sensitive α-subunits of the transcription factors, hypoxia-inducible factor (HIF)-1 and -2, which activate a gene program associated with angiogenesis and glycolysis. Here, we focus on the role of MIF and its mechanism of action in the process of hypoxia-induced angiogenesis and in the regulation of HIFs.

Methods: Therefore, we developed a specific knockdown of MIF and its receptor CD74 in Human Microvascular Endothelial Cell (HMEC) using lentiviral-based shRNA technology allowing us to analyse the role of MIF in hypoxia-induced angiogenesis. We investigated the adaption of these cells towards pathophysiologic hypoxic conditions (1% O2) analysing protein-levels of HIF-1α and HIF-2α, HIF-target gene expression, angiogenesis and VEGFA release. To further identify the underlying mechanisms angiogenesis assay was performed with HMECs treated with anti-CD74-IgG, rhMIF and 4-IPP, a small molecule inhibitor of MIF.

Results: Lentiviral-mediated reduction of MIF in HMEC led to significantly decreased angiogenesis (p<0.01) which could be restored by adding extracellular rhMIF. Interestingly, reduction of MIF did not influence hypoxia-induced (i) protein-levels of HIF-1α and HIF-2α, respectively, and (ii) HIF-target gene expression of PGK1, GAPDH and VEGFA but (iii) induced secretion of pro-angiogenic VEGFA and IL8. Moreover, addition of 4-IPP also decreased angiogenic response of non-transduced HMECs but enhanced the hypoxia-induced HIF-target gene expression of PGK1 and VEGFA. Inhibiting MIF-signalling by the addition of extracellular anti-CD74-IgG also reduced angiogenic potential of HMEC (p<0.001), which was not restorable by the addition of extracellular rhMIF. Furthermore, lentiviral-mediated reduction of CD74 in HMEC also decreased angiogenesis (p<0.01) again without influencing HIF-target gene expression of PGK1, GAPDH and VEGFA.

Conclusion:

Our findings reveal an essential regulatory function of MIF upon the angiogenic potential of HMECs. Hypoxia-induced MIF-dependent induction of angiogenesis is independent of HIF-mediated activation of a gene program associated with angiogenesis and glycolysis including VEGFA secretion. These findings open new possibilities for therapeutic approaches in RA and other inflammatory disorders by targeting specific MIF-mediated signalling events.


Disclosure: M. Mursell, None; M. Hahne, None; P. Kunath, None; C. Strehl, None; P. Hoff, None; F. Buttgereit, None; T. Gaber, None.

To cite this abstract in AMA style:

Mursell M, Hahne M, Kunath P, Strehl C, Hoff P, Buttgereit F, Gaber T. Extracellular Macrophage Migration Inhibitory Factor Is Essential for Hypoxia-Induced Angiogenesis in a Hypoxia Inducible Factor Independent Manner [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/extracellular-macrophage-migration-inhibitory-factor-is-essential-for-hypoxia-induced-angiogenesis-in-a-hypoxia-inducible-factor-independent-manner/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/extracellular-macrophage-migration-inhibitory-factor-is-essential-for-hypoxia-induced-angiogenesis-in-a-hypoxia-inducible-factor-independent-manner/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology